期刊文献+

RP-HPLC法检查羟喜树碱的有关物质 被引量:3

Test related substances of hydroxycamptothecin by rp-hple
下载PDF
导出
摘要 目的:采用RP-HPLC法检查羟喜树碱的有关物质。方法:采用Diamonsil C_(18)(200mm×4.0mm,5μm)色谱柱,流动相:甲醇—水(40:60);检测波长分别为:254nm、266nm、373nm(喜树碱和羟喜树碱的最大吸收波长和两者等吸收系数点波长);柱温:40℃;流速:0.8ml/min。结果:254nm波长处:喜树碱在0.536μg/ml~5.36μg/ml浓度范围內呈良好的线性关系,回归方程Y=5695.7C+56.3,相关系数r=0.9995,最低检测浓度:0.268μg/ml最低检测量,5.36ng。结论:方法简便,快速,准确。可定量测定羟喜树碱中的主要杂质喜树碱。 Objective:To establish RP-HPLC method for the test of the related substances of Hydroxycamptothecin. Methods: The chromatographic conditions included column Diamonsil C18(200mm×4.0mm5um),mobile phase of methanol water(40 : 60)and detector UV 254 nm, 266 nm and 373 nm ,the column temperature was 40℃,the flow rate was 0. 8 mL/min. Results : There was a good linear relationship within the concentration range of 0. 536ug/mL^5. 36ug/mL of Camp-to thecin at 254nm. The regression equation : Y = 5695. 7C + 56. 3 ,r = 0. 9995. Conclusion: This method is simple . quick and accurate for the test of the main substances (Camptothecin)of Hydroxycamptothecin.
出处 《中国药品标准》 CAS 2003年第1期59-62,共4页 Drug Standards of China
关键词 RP-HPLC 羟喜树碱 喜树碱 等吸收系数 RP-HPLC Hydroxycamptothecin Camptothecin related substances Equal specific absorbance
  • 相关文献

参考文献2

二级参考文献5

  • 1张志荣,中国医药工业杂志,1995年,26卷,393页
  • 2张志荣,华西医科大学学报,1994年,25卷,384页
  • 3张志荣,中国医院药学杂志,1994年,14卷,246页
  • 4Ling Y H,中国药理学报,1993年,14卷,546页
  • 5胥彬,医药工业,1985年,16卷,12期,22页

共引文献71

同被引文献24

  • 1方芸,张海霞,谈恒山.雾化吸入与静脉注射羟基喜树碱在兔体内的药动学比较[J].中国药学杂志,2006,41(16):1255-1258. 被引量:6
  • 2[2]Christian B. Homocamptothecins:potent topoisomerase I inhibitors and promising anticancer drugs[J]. Crit Rev Oncol Hematol, 2003 ;45( 1 ) :91 - 108
  • 3[3]Zhang RW, Li YF, Cai QY, Liu TP, Sun H. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I [ J ]. Cancer Chemother Pharmacol, 1998; 41: 257 - 67
  • 4[7]Ma J, Liu CL, Zhu PL, Jia ZP, Xu LT, Wang R. Simultaneous determination of the carboxylate and lactone forms of 10hydroxycamptothecin in human serum by restricted-access media high-performance liquid chromatography [J]. J Chromatogr B,2002; 772:197 - 204
  • 5[8]Zhou J J, Liu Jn, Xu B. Relationship between lactone ring forms of hcpt and their antitumor activities[J]. 中国药理学报,2001;22(9) :827 - 30
  • 6[11]Li YF, Zhang RW. Reversed-phase high-performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissues[J]. J Chromatogr B, 1996;686:257- 65
  • 7[12]Bom D, Curran DP, Zhang J, Zimmer SG, Bevins R, Kruszewski S, et al. The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity [ J]. J Controlled Release, 2001; 74(6) :325 - 33
  • 8胥彬 杨金龙.抗肿瘤药物羟基喜树碱[J].医药工业,1985,16(2):22-22.
  • 9Hatefi A, Amsden B. Camptothecin delivery methods. Pharm Res,2002,19(10) :1389
  • 10Tadros T, Izquierdo P, Esquena J, et al. Formation and stability of nano- emulsions. Adv Colloid Interface Sci,2004,108 -109 (complete) :303

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部